These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial. de Celis-Ruiz E; Fuentes B; Alonso de Leciñana M; Gutiérrez-Fernández M; Borobia AM; Gutiérrez-Zúñiga R; Ruiz-Ares G; Otero-Ortega L; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E Cell Transplant; 2022; 31():9636897221083863. PubMed ID: 35301883 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of GABA Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM; Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836 [TBL] [Abstract][Full Text] [Related]
6. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial. Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW; Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644 [TBL] [Abstract][Full Text] [Related]
7. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of acute mechanical revascularization in large stroke (ASPECTS ⩽5) and large vessel occlusion within 7 h of last-seen-well: The LASTE multicenter, randomized, clinical trial protocol. Costalat V; Lapergue B; Albucher JF; Labreuche J; Henon H; Gory B; Sibon I; Boulouis G; Cognard C; Nouri N; Richard S; Marnat G; Di Maria F; Annan M; Duhamel A; Cagnazzo F; Jovin T; Arquizan C; Int J Stroke; 2024 Jan; 19(1):114-119. PubMed ID: 37462028 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke. Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177 [TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
12. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial. Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic adipose tissue-derived mesenchymal stem cells in ischaemic stroke (AMASCIS-02): a phase IIb, multicentre, double-blind, placebo-controlled clinical trial protocol. de Celis-Ruiz E; Fuentes B; Moniche F; Montaner J; Borobia AM; Gutiérrez-Fernández M; Díez-Tejedor E BMJ Open; 2021 Aug; 11(8):e051790. PubMed ID: 34373315 [TBL] [Abstract][Full Text] [Related]
15. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial. Zhang Q; Wang A; Xu Q; Xia X; Tian X; Zhang Y; Li X; Yang X; Wang X; Peng J; Li Y; Liu L; Jin S; Meng X; Zhao X; JAMA Netw Open; 2023 Aug; 6(8):e2328828. PubMed ID: 37578791 [TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial. Hernández-Jiménez M; Abad-Santos F; Cotgreave I; Gallego J; Jilma B; Flores A; Jovin TG; Vivancos J; Hernández-Pérez M; Molina CA; Montaner J; Casariego J; Dalsgaard M; Liebeskind DS; Cobo E; Castellanos M; Portela PC; Masjuán J; Moniche F; Tembl JI; Terceño Izaga M; Arenillas JF; Callejas P; Olivot JM; Calviere L; Henon H; Mazighi M; Piñeiro D; Pugliese M; González VM; Moro MA; Garcia-Tornel A; Lizasoain I; Ribo M JAMA Neurol; 2023 Aug; 80(8):779-788. PubMed ID: 37338893 [TBL] [Abstract][Full Text] [Related]
18. Stem cell transplantation for ischemic stroke. Boncoraglio GB; Ranieri M; Bersano A; Parati EA; Del Giovane C Cochrane Database Syst Rev; 2019 May; 5(5):CD007231. PubMed ID: 31055832 [TBL] [Abstract][Full Text] [Related]
19. Complete Restoration of Motor Function in Acute Cerebral Stroke Treated with Allogeneic Human Umbilical Cord Blood Monocytes: Preliminary Results of a phase I Clinical Trial. Lee TK; Lu CY; Tsai ST; Tseng PH; Lin YC; Lin SZ; Wang JC; Huang CY; Chiu TL Cell Transplant; 2021; 30():9636897211067447. PubMed ID: 34939863 [TBL] [Abstract][Full Text] [Related]